TG Therapeutics, Inc. (TGTX)
33.39
-0.30
(-0.89%)
USD |
NASDAQ |
Apr 07, 16:00
33.39
0.00 (0.00%)
After-Hours: 17:46
TG Therapeutics Market Cap : 5.332B for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precision BioSciences, Inc. | 154.91M |
| Krystal Biotech, Inc. | 7.707B |
| Amicus Therapeutics, Inc. | 4.544B |
| Geron Corp. | 1.118B |
| MannKind Corp. | 793.36M |
Market Cap Related Metrics
| PE Ratio | 12.02 |
| PS Ratio | 8.746 |
| PEG Ratio | 0.0063 |
| Price to Book Value | 8.228 |
| Price | 33.39 |
| Earnings Yield | 8.32% |
| PEGY Ratio | 0.0063 |
| Operating PE Ratio | 43.71 |
| Normalized PE Ratio | 12.02 |